Analysis of an alternatively spliced exon of the neurofibromatosis type 1 gene in cultured melanocytes from patients with neurofibromatosis 1
✍ Scribed by Ingrid Eisenbarth; Sven Hoffmeyer; Dieter Kaufmann; Günter Assum; Winfrid Krone
- Publisher
- Springer-Verlag
- Year
- 1995
- Tongue
- English
- Weight
- 889 KB
- Volume
- 287
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
✦ Synopsis
Neurofibromatosis type 1 (NF1) is characterized by clinical features that primarily affect tissues derived from the neural crest (neurofibromas, caf~-aulait macules). Because aberrant regulation of alternative splicing in the NF1 gene transcript may be of functional significance, cultured melanocytes from caffi-aulait macules (CALM), as an example of benign NF1 lesions, were examined for the expression of the different alternative splice products of this gene. Both kinds of NF1 messengers (type 1 and 2) were found not only in CALM melanocytes but also in keratinocytes, fibroblasts and blood cells. Except in blood cells, there was a predominance of the type 2 transcript. Melanocytes from NF1 patients and healthy donors showed similar expression patterns under several culture conditions. Our results suggest that the development of CALM does not correlate with a switch in the ratio of type I to type 2 NF1 messenger RNA.
📜 SIMILAR VOLUMES
## Abstract The neurofibromatosis type 1 (__NF__1) gene encodes a 360‐residue region showing significant homology to the catalytic domains of both mammalian GTPase‐activating protein (GAP) and yeast IRA protein. The product of the GAP‐related domain of the __NF__1 gene (__NF__1‐GRD) has been shown
## Communicated by Haig H. Kazazian One of the main features of neurofibromatosis type 1 (NF1) is benign neurofibromas, 10-20% of which become transformed into malignant peripheral nerve sheath tumors (MPNSTs). The molecular basis of NF1 tumorigenesis is, however, still unclear. Ninety-one tumors